Etanercept immunotherapy in women with a history of recurrent reproductive failure

Ginekologia Polska

Volumn 83, Issue 4, 2012, Pages 260-264

  Jerzak, Małgorzata ^a   Ohams, Monika ^b   Górski, Andrzej ^b   Baranowski, Włodzimierz ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Etanercept; In vitro fertilization; NK cell activity; Recurrent miscarriage

Indexed keywords

EID: 84862013159     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Wallace D. The use of etanercept and other tumor necrosis factor-alpha blockers in infertility: it's time to get serious. J Rheumatol. 2003, 30, 1897-1899.
2. Roux C, Brocq O, Breuil V, [et al.]. Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy. Rheumatology (Oxford). 2007, 46, 695-698.
3. Ostensen M, Khamashta M, Lockshin M, [et al.]. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther. 2006, 8, 209-228.
4. Carter J, Ladhani A, Ricca L, [et al.]. A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database. J Rheumatol. 2009, 36, 635-41.
5. Ntrivalas E, Kwak-Kim J, Gilman-Sachs A, [et al.]. Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum Reprod. 2001, 16, 855-861.
6. Aoki K, Kajiura S, Matsumoto Y, [et al.]. Preconceptional natural killer cell activity as a predictor of miscarriage. Lancet. 1995, 345, 1340-1342.
7. Santoni A, Carlino C, Stabile H, [et al.]. Mechanisms underlying recruitment and accumulation of decidual NK cells in uterus during pregnancy. Am J Reprod Immunol. 2008, 59, 417-424.
8. Yamada H, Morikawa M, Kato E, [et al.]. Pre-conceptional natural killer cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with normal chromosome karyotype. Am J Reprod Immunol. 2003, 50, 351-354.
9. King K, Smith S, Chapman M, Sacks G. Detailed analysis of peripheral blood natural killer (NK) cells in women with recurrent miscarriage. Hum Reprod. 2010, 25, 52-58.
10. Jerzak M, Kniotek M, Mrozek J, [et al.]. Sildenafil citrate decreased natural killer cell activity and enhanced chance of successful pregnancy in women with a history of recurrent miscarriage. Fertil Steril. 2008, 90, 1848-1853.
11. De Carolis C, Perricone C, Perricone R. NK cells, autoantibodies, and immunologic infertility: a complex interplay. Clin Rev Allergy Immunol. 2010, 39, 166-175.
12. Guerin L, Prins J, Robertson S. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum Reprod Update. 2009, 15, 517-535.
13. Jerzak M, Niemiec T, Nowakowska A, [et al.]. First successful pregnancy after addition of enoxaparin to sildenafil and etanercept immunotherapy in woman with fifteen failed IVF cycles - case report. Am J Reprod Immunol. 2010, 64, 93-96.
14. Coulam C, Clark D, Beer A, [et al.]. Current clinical options for diagnosis and treatment of recurrent spontaneous abortion. Clinical Guidelines Recommendation Committee for Diagnosis and treatment of Recurrent Spontaneous Abortion. Am J Reprod Immunol. 1997, 38, 57-74.
15. Johann S, Blumel G., Lipp M, Förster R. A versatile flow cytometry-based assay for the determination of short- and long-term natural killer cell activity. J Immunol Methods. 1995, 185, 209-216.
16. Koren G, Inoue M. Do tumor necrosis factor inhibitors cause malformations in humans? J Rheumatol. 2009, 36,465-466.
17. Johnson D, Jones K, Chambers C. Pregnancy Outcome in Women Exposed to Etanercept: The OTIS Autoimmune Diseases in Pregnancy Project. American College of Rheumatology (ACR), San Francisco, 2008.
18. Verstappen S, King Y, Watson K, [et al.]. Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2011, 70, 823-826.
19. Robertson S, Care A, Skinnner R. Interleukin 10 regulates inflammatory cytokine synthesis to protect against lipopolysaccharide-induced abortion and fetal growth restriction in mice. Biol Reprod. 2007, 76, 738-748.
20. Benihoud K, Esselin S, Descamps D, [et al.]. Respective roles of TNF-alpha and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice. Gene Ther. 2007, 14, 533-544.
21. Renaud S, Cotechini T, Quirt J, [et al.]. Spontaneous pregnancy loss mediated by abnormal maternal inflammation in rats is linked to deficient uteroplacental perfusion. J Immunol. 2011, 186, 1799-1808.
22. Winger E, Reed J. Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am J Reprod Immunol. 2008, 60, 8-16.
23. Winger E, Reed J, Ashoush S, [et al.]. Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. Am J Reprod Immunol. 2009, 61, 113-120.
24. Clark D. Anti-TNF alpha therapy in immune-mediated subfertility: state of the art. J Reprod Immunol. 2010, 85, 15-24.
25. Clowse M. The use of anti-TNF-α medications for rheumatologic disease in pregnancy. Int J Womens Health. 2010, 2, 199-209.
26. Thaher F, Plankenhorn S, Klein R. Differential effects of the tumor necrosis factor alpha-blocker infliximab and etanercept on immunocompetent cells in vitro. Int Immunopharmacol. 2011, 11, 1724-31.
27. Tang A, Alfirevic Z, Quenby S. Natural killer cells and pregnancy outcomes in women with recurrent miscarriage and infertility: a systematic review. Hum Reprod. 2011, 26, 1971-80.